PlainRecalls
FDA Drug Low Class III Terminated

ClomiPHENE CITRATE Tablets, USP, 50 mg, 10-count (2 foil sealed plastic trays of 5 tablets each) per carton, Rx only, Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD., Jerusalem, 91010, Israel; Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960; NDC 0093-0041-03, UPC 3 0093-0041-03 7.

Reported: September 23, 2015 Initiated: September 10, 2015 #D-1813-2015

Product Description

ClomiPHENE CITRATE Tablets, USP, 50 mg, 10-count (2 foil sealed plastic trays of 5 tablets each) per carton, Rx only, Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD., Jerusalem, 91010, Israel; Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960; NDC 0093-0041-03, UPC 3 0093-0041-03 7.

Reason for Recall

Chemical Contamination: impurity failure due to chemical contamination of the active ingredient.

Details

Recalling Firm
EMD Serono, Inc.
Units Affected
37,078 cartons
Distribution
Nationwide
Location
Rockland, MA

Frequently Asked Questions

What product was recalled?
ClomiPHENE CITRATE Tablets, USP, 50 mg, 10-count (2 foil sealed plastic trays of 5 tablets each) per carton, Rx only, Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD., Jerusalem, 91010, Israel; Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960; NDC 0093-0041-03, UPC 3 0093-0041-03 7.. Recalled by EMD Serono, Inc.. Units affected: 37,078 cartons.
Why was this product recalled?
Chemical Contamination: impurity failure due to chemical contamination of the active ingredient.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 23, 2015. Severity: Low. Recall number: D-1813-2015.